Rare Zebra

Rare disease search prototype built on Orphanet data

← Back to search

ORPHA:293173

Acute generalized exanthematous pustulosis

Also called AGEP, Pustular drug eruption, Toxic pustuloderma

Body system
Skin diseases
Inheritance pattern
Multigenic/multifactorial, Not applicable
Typical age of onset
All ages
Estimated prevalence
1-9 / 1 000 000 (Worldwide)
Rarity class
1-9 / 1 000 000

About this disease

A rare hypersensitivity reaction characterized by the rapid development of numerous, nonfollicular, sterile, pinhead-sized pustules on an erythematous base, predominantly occurring on the trunk, intertriginous and flexural areas, with rare, mostly oral, mucosal involvement. Fever, peripheral blood leukocytosis, and mild eosinophilia are accompanying features. Systemic involvement, with hepatic, renal or pulmonary dysfunction, occasionally occurs. Onset usually occurs 1-12 days after administration of the causal medication and is most frequently associated with beta‐lactam antibiotics, macrolides (including pristinamycin and clindamycin), diltiazem, terbinafine, (hydroxy‐)chloroquine but many other medications have also been implicated. Histology reveals spongiform, subcorneal and/or intraepidermal, pustules but this pattern is not specific (same in pustular psoriasis).

Definition from Orphanet.

Common signs

  • Increased total leukocyte count
  • Pustule
  • Pruritus
  • Increased total eosinophil count
  • Fever
  • Elevated erythrocyte sedimentation rate

Learn more

  • OrphanetORPHA:293173
  • ICD-11EH67.0
  • MonarchMONDO:0017384